Document is current
Any future updates will be listed below
-
Authors
Kallman, Alyssa
Capowski, Elizabeth E. https://orcid.org/0000-0002-8204-5434
Wang, Jie https://orcid.org/0000-0002-7491-7001
Kaushik, Aniruddha M.
Jansen, Alex D.
Edwards, Kimberly L.
Chen, Liben
Berlinicke, Cynthia A.
Joseph Phillips, M.
Pierce, Eric A.
Qian, Jiang
Wang, Tza-Huei
Gamm, David M.
Zack, Donald J. https://orcid.org/0000-0002-7966-1973
-
Funding
Funding for this research was provided by:
Foundation Fighting Blindness
Research to Prevent Blindness
Maryland Stem Cell Research Fund
- License Information
-
More Information
Article History
Received: 28 August 2019
Accepted: 21 January 2020
First Online: 21 February 2020
Competing interests
: D.M.G. and M.J.P. have an ownership interest in Opsis Therapeutics LLC, which has licensed the technology to generate optic vesicles from pluripotent stem cell sources reported in this publication. D.M.G. also declared intellectual rights through the Wisconsin Alumni Research Foundation and a consultant role with FUJIFILM Cellular Dynamics International. All other authors indicated no potential conflicts of interest.
